R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2026
Back to search
Official data from USPTO
ASPEYA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000098806452Class
5, 10, 30, 32, 42, 44
Filing
98806452
Registration
8182964
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 10, 30, 32, 42, 44
Filing date
10/17/2024
Registration date
03/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
33
Owner location
LAUSANNE, CH
Examiner
HOPKINS, SARAH COLLEEN
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a fan with four prongs in the shape of a triangle to the left of the word "ASPEYA" in capital letters.
Holders and representatives
Holders
ASPEYA SWITZERLAND SA
Vectura Fertin Pharma Switzerland S.A.
Representatives
Tamar Niv Bessinger Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5Class 10Class 30Class 32Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productssmoking cessation preparationsanalgesic preparationssleep aid- preparationsanti-pyretic and anti-inflammatory preparationspreparations for the treatment of arthritispreparations having psychotherapeutic properties for the treatment mental health conditionspreparations for treatment of coldflucoughsinusallergycardiovascular emergenciesneurological conditionschronic pain managementgastro-intestinal disorders; pharmaceutical products for inhalationsmoking cessation preparationsanalgesic preparationssleep aid-preparationsantipyretic and anti-inflammatory preparationspreparations for the treatment of arthritispreparations having psychotherapeutic properties for the treatment of mental health conditionspreparations for treatment of coldflucoughsinusallergycardiovascular emergenciesneurological conditionschronic pain managementgastro-intestinal disorders; pharmaceutical productssmoking cessation preparationsanalgesic preparationssleep aid-preparationsanti-pyretic and anti-inflammatory preparationspreparations for the treatment of arthritispreparations having psychotherapeutic properties for the treatment of mental health conditionspreparations for treatment of coldflucoughsinusallergycardiovascular emergenciesneurological conditionschronic pain managementgastro-intestinal disorders in chewable formin gum formin lozenge formin pouch powder form; nutraceuticals for the treatment of arthritispreparations having psychotherapeutic properties for the treatment of mental health conditionspreparations for treatment of coldflucoughsinusallergycardiovascular emergenciesneurological conditionschronic pain managementgastro-intestinal disorders; vitamins and dietary supplements; pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions being coldflucoughsinusallergycardiovascular emergenciesneurological conditionschronic pain managementgastro-intestinal disorders; pharmaceutical preparations for treatment of a wide variety of diseases and conditions being coldflucoughsinusallergycardiovascular emergenciesneurological conditionschronic pain managementgastro-intestinal disorders in chewable formin gum formin lozenge formin pouch powder form; nicotine chewing gum for use as an aid to stop smoking
Class 10
Medical devices for use for inhalation of pharmaceutical preparationssold empty; medical devices sold empty for use for inhalation of aerosolized or inhaled therapeutics and pharmaceuticals; inhalers for therapeutic purposessold empty; dry powder inhalers (DPI) for therapeutic purposessold empty; nebulizer for medical purposes; pressurized metered dose inhalers (pMDI) for therapeutic purposessold empty
Class 30
mixes in the nature of syrupspowdersconcentrates for flavoring being preparation of non-alcoholic beverages being tea based beverages; non-alcoholic beveragestea
Class 32
Non-alcoholic beveragesflavored waters and mineral and aerated waters; Pastilles and powders for effervescing beverageseffervescent tablets and powders for making sports drinks and soft drinks; Energy drinks; Isotonic beverages; Protein enriched sports beverages; Whey beverages; Syrups and other preparations for making non-alcoholic beveragesconcentratessyrupspowders used in the preparation of soft drinkstea-flavored beveragesfruit flavored beverages
Class 42
Medical research services; scientific research services in the field of smoking cessation preparationsanalgesic preparationssleep aid-preparationsanti-pyretic and anti-inflammatory preparationspreparations for the treatment of arthritispreparations having psychotherapeutic propertiespreparations for treatment of coldflucoughsinusallergycardiovascular emergenciesneurological conditionschronic pain managementgastro-intestinal disorders; pharmaceutical drug development services; researchdevelopment of inhaled therapeutics; researchdevelopment of pharmaceutical and well-being products for oral and intraoral delivery systems
Class 44
Medical services; medical services in the area of inhaled therapeutics and pharmaceuticals and in the area of oral administration of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
30 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/03/2026
PUBO
PUBLISHED FOR OPPOSITION
02/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/28/2026
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/09/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/30/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/30/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/30/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/30/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/30/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12/01/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12/01/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/02/2025
GNFR
FINAL REFUSAL E-MAILED
09/02/2025
CNFR
FINAL REFUSAL WRITTEN
09/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/05/2025
GNRT
NON-FINAL ACTION E-MAILED
05/05/2025
CNRT
NON-FINAL ACTION WRITTEN
05/05/2025
DOCK
ASSIGNED TO EXAMINER
04/28/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/27/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/11/2025
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
12/26/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/26/2024
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
11/20/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/20/2024
NWAP
NEW APPLICATION ENTERED
10/17/2024
Continuous trademark protection
Get notified about every new filing that threatens ASPEYA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.